Showing results (121-130 of 157) with videos related to
Sort By:
Pageof 16
The Journal of Clinical Endocrinology and Metabolism|July 13, 2006
Pamidronate reduces bone loss after allogeneic stem cell transplantationA P Grigg, P Shuttleworth, J Reynolds, et al.Leukemia & Lymphoma|December 29, 2004
Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabineA P Grigg, J Reynolds, A McQuillan, et al.Leukemia & Lymphoma|July 16, 2005
Autografting followed by rituximab for chemosensitive mantle cell lymphoma: a pilot study and literature reviewA P Grigg, J Bashford, J F Seymour, et al.Medicine|August 15, 2020
Maternal bacteria to correct abnormal gut microbiota in babies born by C-sectionÉadaoin M Butler, Valentina Chiavaroli, José G B Derraik, et al.Leukemia|July 16, 2016
The clinical significance of ABCB1 overexpression in predicting outcome of CML patients undergoing first-line imatinib treatmentL N Eadie, P Dang, V A Saunders, et al.Thrombosis Research|August 6, 2016
The tyrosine kinase inhibitor, nilotinib potentiates a prothrombotic stateNaif Alhawiti, Kate L Burbury, Faith A Kwa, et al.Internal Medicine Journal|July 1, 2008
Antifungal prophylaxis in adult stem cell transplantation and haematological malignancyM A Slavin, C H Heath, K A Thursky, et al.Leukemia & Lymphoma|March 12, 2010
Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphomaAndrew P Grigg, Janey Stone, Alvin D Milner, et al.Blood|December 15, 1991
Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected]H G Klingemann, A P Grigg, K Wilkie-Boyd, et al.Internal Medicine Journal|November 10, 2018
Recommendations for the use of pegylated interferon-α in the treatment of classical myeloproliferative neoplasmsCecily J Forsyth, Wai-Hoong Chan, Andrew P Grigg, et al.Pageof 16